Search

Issue
Title
Authors
Obespechennost' vitaminom D i metabolicheskie narusheniya: sistematicheskiy analiz fundamental'nykh i dokazatel'nykh issledovaniy po problemam izbytochnoy massy tela i sakharnogo diabeta
Gromova O.A., Torshin I.Y., Limanova O.A., Grishina T.R., Gromov A.N.
Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol'nym sakharnym diabetom 2011 g.: osnovnye izmeneniya
Mayorov A.Y.
Modern drug approaches to glycemic control in patients with type 1 and 2 diabetes mellitus
Bagriy A.E., Shchukina E.V., Efremenko V.A., Mikhailichenko E.S., Suprun E.V.
Combination therapy for type 2 diabetes maintains its position. Clinical case
Podachina S.V., Biryukova E.V., Solovievа I.V.
Monogennye formy sakharnogo diabeta
Zubkova N.A., Tikhonovich Y.V., Tyul'pakov A.N.
SITAGLIPTIN: CURRENT POSITIONS AND PROSPECTS FOR THERAPY OF TYPE 2 DIABETES MELLITUS
Druk I.V., Nechaeva G.I., Korennova O.Y., Druk I.V., Nechayeva G.I., Korennova O.Y.
Tactics of hypoglycemic treatment in patients with pancreatogenic diabetes: a prospective study
Nikulin I.Y., Bagriy A.E., Mikhailichenko E.S., Kutya A.E., Sovpel Y.A.
SAXAGLIPTIN OPENS NEW OPPORTUNITIES FOR EFFECTIVE AND SAFE GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Mkrtumyan A.M., Mkrtumyan A.M.
Possibilities of dapagliflozin in cardio-reno-metabolic protection in patients with and without type 2 diabetes mellitus
Antsiferov M.B., Koteshkova O.M., Novikova M.S., Demidov N.A.
Does autoimmune thyroiditis affect the clinical course of type 1 diabetes mellitus in children, regardless of the functional state of the thyroid gland?
Abdullaev A.N., Litvinova D.V., Rozhkov N.I., Kiyaev A.V.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A.F., Sharonova L.A., Verbovaya N.I., Demidova D.V., Kapishnikov A.V.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.A.
Dipeptyl peptidase type 4 inhibitors for modern therapy of type 2 diabetes mellitus
Demidov N.A.
Ipragliflozin in the treatment of comorbid patients with type 2 diabetes mellitus
Chernikova N.A., Knyshenko O.A., Ivanova L.P.
Ingibitory SGLT-2: farmakologicheskaya glyukozuriya kak novyy podkhod v upravlenii SD 2 tipa
Demidova T.Y.
Practical aspects of the use of semaglutide (Ozempic®) in real clinical practice
Antsiferov M.B., Zilov A.V., Koteshkova O.M., Demidov N.A.
Novyy klass antidiabeticheskikh preparatov - ingibitory natriy-glyukoznykh kotransporterov
Ushkalova E.A.
Experience with the use of valsartan/sacubitril in patients with chronic heart failure in combination with type 2 diabetes mellitus and paroxysmal atrial fibrillation
Ignatenko A.G., Bagriy A.E., Prikolota A.V., Prikolota O.A., Mikhailichenko E.S., Golodnikov I.A., Bagriy O.N.
The use of sodium-glucose co-transporter type II (SGLT2) inhibitors in patients with chronic heart failure against the background of type 2 diabetes mellitus
Petrov V.I., Shatalova O.V., Klykova M.S., Stetsky N.P.
Efficacy and safety of ertugliflozin: results of the VERTIS CV sub-study in patients receiving a stable dose of insulin
Novikova M.S., Koteshkova O.M., Antsiferov M.B.
School of diabetes: new education module on insulin pump for patients with type 1 diabetes mellitus
Lisker A.V., Volkova A.R., Chernaya M.E., Mozgunova V.S., Durdyeva M.B.
Resistin levels and metabolic parameters in patients type 2 diabetes mellitus in combination with hypothyroidism
Verbovoy T.V., Lomonova T.V.
Alogliptin in the treatment of type 2 diabetes mellitus: an evidence base for the clinical use
Biryukova E.V.
Adipokiny i gormonal'no-metabolicheskie pokazateli u bol'nykh sakharnym diabetom 2 tipa i podagroy
Verbovoy A.F., Tsanava I.A., Verbovaya N.I.
UPRAVLENIE SAKhARNYM DIABETOM: ZNAChENIE STRUKTURIROVANNOGO SAMOKONTROLYa
Antsiferov M.B., Koteshkova O.M.
Osobennosti terapii perenesennogo insul'ta u bol'nykh sakharnym diabetom
Shavlovskaya O.A.
Rol' i mesto gipoglikemii v upravlenii sakharnym diabetom 2 tipa
Chernikova N.A., Antsiferov M.B.
O RATsIONAL'NOM VYBORE FARMAKOTERAPII PRI SAKhARNOM DIABETE 2 TIPA
Biryukova E.V.
DIABETES IN CHILDREN AND ADOLESCENTS: TO THE 90TH ANNIVERSARY OF THE INTRODUCTION OF INSULIN IN CLINICAL PRACTICE
Peterkova V.A., Peterkova V.A.
HOW TO ACHIEVE EFFECTIVE GLYCEMIC CONTROL AND REDUCE THE RISK OF VASCULAR COMPLICATIONS DUE TO USING SULFONYLUREA MEDICATIONS
Biryukova E.V., pl?midmagidsid Y.h.
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS
Antsiferov M.B., Koteshkova O.M., Kleimenova S.A., Antsiferov M.B., Koteshkova O.M., Kleymenova S.A.
Common bean (Phaseolus vulgaris L.)/
Samylina I.A., Sorokina A.A., Pyatigorskaya N.V., Samylina I., Sorokina A., Pyatigorskaya N.
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries)
Antsiferov M.B., Antsiferov M.
LEChENIE BOL'NYKh SAKhARNYM DIABETOM TIPA 2: PROBLEMY I PUTI IKh REShENIYa
Petunina N.A.
Optimization of approaches to the treatment of obesity in patients with type 2 diabetes mellitus
Kurnikova I.A., Chekalina M.S., Ualikhanova A.U.
Deintensification of insulin therapy in elderly patients with type 2 diabetes mellitus: impact on glycemic control and risk of hypoglycemia
Glinkina I.V., Oderiy A.V., Galkina A.P., Berdygylydzhova G.S., Fadeev V.V.
Efficacy and safety of fixed combination insulin glargine 100 u/ml and lixisenatide in patients with type 2 diabetes mellitus depending on age and baseline HbA1C in the SOLO study
Antsiferov M.B., Demidov N.A., Safronova T.I., Mishra O.A.
The role of menopausal hormone therapy in the prevention of type 2 diabetes melltus in postmenopausal women
Apetov S.S., Apetova V.V.
P-cell dysfunction in type 2 diabetes mellitus: the possibilities of modern antihyperglycemic therapy
Chernikova N.A.
The choice of antianginal therapy for polymordib patients with coronary artery disease and type 2 diabetes mellitus: the benefits of trimetazidine
Kochetkov A.I., Pereverzev A.P., Ostroumova O.D., Gusenbekova D.G., Romanovsky R.R., Shatalova N.A.
Effect of Subetta on glycemic control in patients with type 2 diabetes mellitus: results of a multicenter, double-blind, placebo-controlled, randomized clinical study
Mkrtumyan A.M., Vorobyev S.V., Volkova A.R., Vorokhobina N.V.
Is it possible to stop the diabetes epidemic?
Verbovoy A.F., Dolgikh Y.A., Verbovaya N.I.
Hypoglycemic drugs and drug-induced heart failure
Ostroumova O.D., Goloborodova I.V.
The state of carbohydrate metabolism and the development of cerebrovascular diseases in patients with type 2 diabetes mellitus
Antonova K.V., Tanashyan M.M., Maksimova M.Y., Shakhparonova N.V., Romantsova T.I.
Disturbances of the autonomic innervation of the cardiovascular system and hemostasis: their role in the change of microcirculation in patients with type 2 diabetes mellitus
Tsvetkova I.G., Kaukova A.N., Belyakova N.A., Vasyutkova O.A., Konovalova O.V., Lareva A.V.
EFFICIENCY AND SAFETY OF USE OF CANAGLIFLOZIN IN THE OUTPATIENT PRACTICE
Demidov N.A., Antsiferov M.B., Dorofeeva L.G.
APPLICATION OF SAXAGLIPTIN AND ITS COMBINATION WITH METFORMIN IN THE THERAPY OF TYPE 2 DIABETES MELLITUS IN ELDERLY PATIENTS
Antsiferov M.B.
Gipoglikemiya i kachestvo zhizni bol'nykh sakharnym diabetom 2 tipa
Antsiferov M.B., Nikitina T.P., Rodionova A.Y., Kurbatova K.A., Ionova T.I.
Fiksirovannaya kombinatsiya saksagliptina i metformina modifitsirovannogo vysvobozhdeniya - novyy shag v uluchshenii priverzhennosti k lecheniyu sakharnogo diabeta 2 tipa
Biryukova E.V.
Upravlenie lipotoksichnost'yu v debyute sakharnogo diabeta 2 tipa
Ametov A.S., Tertychnaya E.A.
SAKhARNYY DIABET 2 TIPA I NEALKOGOL'NAYa ZhIROVAYa BOLEZN' PEChENI: PRAKTIChESKIE REKOMENDATsII DLYa ENDOKRINOLOGOV
Ametov A.S.
Vybor gliptinov v raznykh klinicheskikh situatsiyakh - kommentarii k portretam patsientov
Ruyatkina L.A., Sorokin M.Y.
Rol' terapevticheskogo obucheniya patsientov na pompovoy insulinoterapii
Ametov A.S., Valitov B.I., Chernikova N.A., Antsiferov M.B.
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Antsiferov M.B., Antsiferov M.B.
RESULTS OF OBSERVATIONAL PROGRAM ON USE OF INSULIN GLARGINE (LANTUS®) IN COMBINATION WITH ORAL HYPOGLYCEMIC AGENTS FOR THE TREATMENT OF TYPE 2 DIABETES MELLITUS IN ROUTINE CLINICAL PRACTICE
Glinkina I.V., Romantsova T.I., Glinkina I.V., Romantsova T.I.
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS
Antsiferov M.B., Antsiferov M.B.
SOVREMENNYE PODKhODY K LEChENIYu SAKhARNOGO DIABETA TIPA 2 U MUZhChIN
Tishova Y.A., Kalinichenko S.Y.
Metformin - pathogenetic drug of first-line in the treatment of type 2 diabetes
Zilov A.V., Zilov A.V.
Dynamics of the structure of non-insulin antihyperglycemic drug use in the treatment of type 2 diabetes mellitus (data from the Moscow segment Federal Diabetes Registry)
Demidov N.A.
News of medicine
Kudinova S.
Combination of two hypoglycemic drugs for type 2 diabetes mellitus
Morgunova T.B., Fadeyev V.V.
Hyperglycemia and ischemic stroke: clinical features in patients with type 2 diabetes mellitus
Izhbuldina G.I., Novikova L.B.
Type 1 diabetes mellitus in Moscow -2018 (according to the Moscow segment of the Federal Diabetes Register)
Demidov N.A., Mishra O.A., Antsiferov M.B.
POSSIBILITIES OF METHORMINE IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS: TEST OF TIME
Biryukova E.V., Solovyeva I.V., Platonova N.M.
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O.S., Sobolev A.A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M.E., Turkina S.V., Tyshchenko I.A., Fabritskaya S.V., Poletaeva L.V.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y.V., Veliyeva O.A.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M.B., Schernthaner G.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I.G., Petryaykina E.E., Koltunov I.E.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M.B., Koteshkova O.M.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.S.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E.V., Danilova T.B.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E.E., Rashid M.A., Antsiferov M.B.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A.S., Kulidzhanyan N.K., Shurupova I.V., Trifonova T.A., Antsiferov M.B.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N.A., Prudnikova M.A., Chernikova N.A., Prudnikova M.A.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I.V., Smirnova O.M., Smirnova O.M., Kononenko I.V.
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y.V., Dedov I.I., Mayorov A.Y., Surkova E.V., Dedov I.I.
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T.Y., Demidova T.Y.
New possibilities for type 2 diabetes mellitus therapy. Results of a pilot observation program of efficacy and safety of the drug «Galvus» (vildagliptin) therapy in Moscow and in the regions of the Russian Federation
Pavlova M.G., Pavlova M.
Primenenie bazal'no-bolyusnogo rezhima insulinoterapii u bol'nykh sakharnym diabetom tipa 2
Antsiferov M.B., Morgunov L.Y.
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
Antsiferov M.B.
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
Antsiferov M.B., Koteshkova O.M., Sitnikov V.V., Mityaeva O.A., Pashintseva L.P., Budantseva T.A., Ivanova E.A., Anciferov M.B., Koteshkova O.M., Sitnikov V.V., Mityaeva O.A., Pashinceva L.P., Budanceva T.A., Ivanova E.A.
Potentials for the use of azilsartan and spironolactone in patients with arterial hypertension and diabetes mellitus
Ignatenko G.A., Bagriy A.E., Mikhailichenko E.S., Prikolota A.V., Mogilevskaya K.E., Sabelnikova Y.S., Belikov V.A.
Possibilities of using a fixed combination of alogliptin and pioglitazone in patients with type 2 diabetes mellitus in everyday clinical practice
Elsukova O.S., Nikitina E.A., Chuprova A.V., Kaysina O.A.
Modern and safe treatment of type 2 diabetes mellitus. Clinical case of the use of gozogliptin in the treatment of a patient with decompensated diabetes mellitus
Smirnova E.Y.
Modern practice of lipid-lowering pharmacotherapy: the choice of the optimal fixed combination
Biryukova E.V., Shinkin M.V., Morozova I.A.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A.D., Zhulina Y.S., Rozhkova V.V., Martynova E.Y., Poteshkin Y.E.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N.I., Panenko S.O., Golubeva A.O.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T.A., Salukhov V.V., Zemlyanoy A.B., Chebykina O.E.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L.Y., Andreeva L.S., Davydova A.V., Chugunova E.V., Tokareva N.P., Molodtsova N.Y.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N.A., Knyshenko O.A.
Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts
Expert C.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A.F., Lomonova T.V., Sharonova L.A.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A.V., Kondrashova O.E., Chernykh L.G., Pollyak O.Y., Yusupova A.R., Slovak M.A., Zaykova I.O.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.A.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.B.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.R.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.S.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N.V., Shamkhalova M.S.
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T.V., Nikonova T.V.
1 - 100 of 208 Items 1 2 3 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"